Description

According to StrategyHelix, the global hemodynamic monitoring system market is expected to increase by US$ 568.9 million during 2022-2028, expanding at a CAGR of 6.1% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for hemodynamic monitoring system. The global hemodynamic monitoring system market is segmented on the basis of type, product, end user, and region. Based on type, the global hemodynamic monitoring system market is categorized into invasive hemodynamic monitoring system, minimally invasive hemodynamic monitoring system, non-invasive hemodynamic monitoring system. On the basis of product, the global hemodynamic monitoring system market has been segmented into disposables, hemodynamic monitoring systems. By end user, the global hemodynamic monitoring system market has been segmented into ambulatory care centers, hospitals & clinics, others. Geographically, the global hemodynamic monitoring system market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The hemodynamic monitoring system market is further segmented into monitoring sensors, oesophageal doppler, pulmonary artery catheters, pulse contours, and others. Furthermore, the disposable market has been categorized into airflow sensors, circuits, probes, and others.

The global hemodynamic monitoring system market is highly competitive. The report also includes the profiles of leading companies such as Baxter International Inc. (Cheetah Medical Inc), CNSystems Medizintechnik GmbH, Deltex Medical plc, Draegerwerk AG & Co KGaA, Edwards Lifesciences Corporation, Getinge AB, ICU Medical Inc., ImaCor Inc., LiDCO Group PLC, N.I. Medical Ltd., Nihon Kohden Corporation, Osypka Medical GmbH, Vygon SAS.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the hemodynamic monitoring system market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Type: invasive hemodynamic monitoring system, minimally invasive hemodynamic monitoring system, non-invasive hemodynamic monitoring system
Product: disposables, hemodynamic monitoring systems
End user: ambulatory care centers, hospitals & clinics, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global hemodynamic monitoring system market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Hemodynamic monitoring system market overview
Part 3. Market breakdown by type
– Invasive hemodynamic monitoring system
– Minimally invasive hemodynamic monitoring system
– Non-invasive hemodynamic monitoring system
Part 4. Market breakdown by product
– Disposables
– Hemodynamic monitoring systems
Part 5. Market breakdown by end user
– Ambulatory care centers
– Hospitals & clinics
– Others
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Baxter International Inc. (Cheetah Medical, Inc)
– CNSystems Medizintechnik GmbH
– Deltex Medical plc
– Draegerwerk AG & Co KGaA
– Edwards Lifesciences Corporation
– Getinge AB
– ICU Medical, Inc.
– ImaCor, Inc.
– LiDCO Group PLC
– N.I. Medical Ltd.
– Nihon Kohden Corporation
– Osypka Medical GmbH
– Vygon SAS
About StrategyHelix
Disclaimer